STAT+: Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity
Incyte (INCY) agreed to pay $12.6 million to settle allegations that donations amounted to kickbacks…
Author: STAT
Opinion: STAT+: Faster approval of complex generics is central to affordable, equitable care
The push to improve Americans’ use of effective and less-expensive generic medications is getting a…
Opinion: Dollar stores: gateways to equitable Covid-19 vaccine distribution
With the number of Americans receiving Covid-19 vaccines each week starting to decline, it’s time…
Years ago, a syringe exchange helped end a devastating HIV outbreak. Now it might be forced to close
The Indiana county at the center of a devastating HIV crisis in 2015 may soon…
STAT+: ‘In their own bubble’: How a cancer center promoted an exclusive experimental drug to attract patients
A new medication for children with a rare and life-threatening cancer called neuroblastoma had a…
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive
The U.S.’s stunning endorsement of a proposal to waive Covid-19 vaccine patents has won plaudits…
STAT+: Biogen’s Alzheimer’s drug may only be cost effective at $2,500 a year
The controversial, but widely anticipated Biogen (BIIB) treatment for Alzheimer’s would only be cost-effective if…
U.S. will back proposal to waive patent rights and boost Covid-19 vaccine production
In a significant move to combat the Covid-19 pandemic, the U.S. government agreed to support…
STAT+: Pharmalittle: Pharma showers a key Democratic senator with cash; Lilly exec accused of altering factory documents
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: The long wait for Cel-Sci to finally admit its cancer drug doesn’t work
Eventually, Cel-Sci will have to disclose the results of its Phase 3 cancer clinical trial….
Opinion: Listen: A physician and a philosopher on long Covid’s mind-body mystery
In this week’s episode of the “First Opinion Podcast,” I talk with critical care physician…
STAT+: Roger Perlmutter, former Merck R&D head, becomes CEO of super-microscopy startup
Roger Perlmutter, previously the head of research at Merck, said Wednesday he will become the…
STAT+: Pharma showers Menendez with rare, off-cycle burst of campaign cash as Democrats eye drug pricing reforms
WASHINGTON — Sen. Bob Menendez doesn’t face reelection until 2024, but pharmaceutical executives are already…
Opinion: India’s ‘vaccine heist’ and lax regulatory oversight imperil global vaccine access
When Covid-19 began sweeping across the globe in 2020, many experts expected India to be…
The editor of digital health’s newest journal wants to democratize medicine with data
As an ICU physician, Leo Anthony Celi knows the immense power health data can hold….
White House aims to give 70% of American adults at least one vaccine dose by July 4
WASHINGTON — The Biden administration on Tuesday set a new goal for the ongoing U.S….
STAT+: Affinia Therapeutics raises $110 million for gene therapy treatments
Affinia Therapeutics, a Waltham-based biotech working on gene therapies to treat diseases using technology developed…
.jpg)
STAT+: Rising wholesale drug prices really do matter to half of all commercially insured Americans
Although the pharmaceutical industry argues that wholesale prices do not accurately reflect prescription drug costs,…
STAT+: Pharmalittle: Pfizer Covid-19 vaccine to generate $26 billion in 2021 sales; EMA reviews Sinovac Covid-19 vaccine
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT+: STAT+ Conversations: An update from STAT’s Pharmalot
Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Gilead sues Russia over a compulsory license issued to a company making remdesivir
Amid worldwide clamoring for Covid-19 vaccines and other therapies, Gilead Sciences (GILD) last month filed…
Opinion: Unlocking federal funding for fentanyl test strips will save lives
It has been said that the opposite of addiction is connection. Covid-19, however, has frayed…
STAT+: 5 virtual physical therapy startups to watch
Virtual physical therapy could almost be considered an oxymoron. Physical therapy, key to recovering from…
STAT+: Biden’s Medicaid pressure tactics could put his team at odds with hospitals
WASHINGTON — The Biden administration is pressuring states to expand Medicaid — and it’s setting…
A doctor trained nurse practitioners to do colonoscopies. Critics say his research exploited Black patients
At a time when medical researchers are under pressure to increase diversity in clinical trials,…
STAT+: How a startup beat health care heavyweights to win Medicare’s AI contest
A $1 million government contest to predict health problems with artificial intelligence attracted the heavyweights…
.jpg)
STAT+: European Commission fines a Merck KGaA unit for providing misleading info prior to a merger
The European Commission fined a unit of Merck KGaA $9 million for providing incorrect or…
STAT+: Roivant Sciences to go public through $7.3 billion SPAC deal
Roivant Sciences, the biotech company once pitched as a Berkshire Hathaway for the pharmaceutical industry,…
STAT+: Pharmalittle: U.S. trade rep to talk with WTO about IP and Covid-19 vaccines; WHO’s Tedros plans to seek re-election
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Sarepta’s more potent Duchenne treatment shows promise, greater toxicity, in small study
Sarepta Therapeutics said Monday that a second-generation medicine for patients with a certain type of…
Opinion: People recover from addiction. They also go on to do good things
The news about addiction — rising rates of addiction, record numbers of overdose deaths, and…
Opinion: STAT+: How the FDA’s ‘master plan’ will affect NIH funding for digital medicine projects
The term B.C. took on a new meaning — Before Covid — last year when…
STAT+: Amgen’s KRAS cancer drug had a bad week, but worry about pricing, not safety
Investors do not like surprises with negative overtones, so they reacted badly when Amgen announced…
Watch: What’s the deal with fecal transplants?
For more than a decade, scientists have been experimenting with a procedure known as a…
WHO’s Tedros plans to seek reelection, setting up referendum on his leadership
Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, plans to run for a…
Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims
Six patients with dementia traveled to Mexico last year to be injected with a gene…
Opinion: India’s Covid-19 catastrophe reflects years of neglecting its health system
Covid-19 is surging uncontrollably throughout India, disrupting big cities like Mumbai and devastating rural areas…
STAT+: Eli Broad, whose gift established a science powerhouse, dies at 87
Eli Broad, the billionaire entrepreneur whose philanthropy enabled the creation of the Broad Institute of…
STAT+: Brazilian senate votes to suspend patents in bid to widen access to Covid-19 vaccines
After a year of politicking, the Brazilian senate passed a bill that would permit the…
HHS to prioritize newborn screening programs’ pipette tip orders
Programs that screen newborns for potentially deadline genetic conditions will now have higher priority when…
STAT+: U.S. government has invested $6 billion in Moderna’s Covid-19 vaccine
The federal government has now invested about $6 billion in the Covid-19 vaccine from Moderna,…
STAT+: Pharmalittle: Wyden goes back to the drawing board on drug pricing; Emergent undergoes an executive shake-up
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Top Senate Democrat heads back to drawing board on drug pricing
WASHINGTON — A powerful Democratic committee chair is starting to work on a new drug…
Virologist Angela Rasmussen on the controversy surrounding Russia’s Sputnik V Covid-19 vaccine
By all accounts, the Covid-19 vaccine developed by Russia’s Gamaleya Institute, called Sputnik V, has…
Opinion: STAT+: Improving health care means improving data diversity. Federated learning can help
Many companies are developing innovative artificial intelligence solutions for health care. Too often, though, these…
Opinion: ALS groups to the FDA and drug sponsors: ‘We won’t be played again’
Working to improve the fight for therapies for amyotrophic lateral sclerosis (ALS, also known as…
Do public health officials need to be political activists? A fight over an HIV crisis renews the question
Most local health officials don’t accept their jobs expecting to be roped into political activism….
Listen: Biden’s punt on drug prices, Russia’s vaccine controversy, & the importance of tiny plastic cones
Does President Biden really care about drug prices? Is Sputnik V falling out of orbit?…
STAT+: Did someone say patent thicket? AbbVie CEO to testify before Congress about drug pricing tactics
As part of its probe into pharmaceutical industry pricing tactics, a Congressional committee next month…
STAT+: Global spending on medicines could hit $1.6 trillion by 2025 — and that doesn’t include Covid-19 vaccines
Global spending on medicines is forecast to grow between 3% and 6% annually and reach…